Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| Yesterday 4:36 PM View:  | Eastham Karin Director | Veracyte, Inc. (VCYT) | 19-Nov-24 | Private Sale (Planned) | 14,731 | $38.34 | $564,768.00 | (44%) 33.23K to 18.5K | |
| 14-Nov-24 4:35 PM View: | Epstein Robert S Director | Veracyte, Inc. (VCYT) | 12-Nov-24 | Planned Option Sale | 15,000 | $38.32 | $574,830.00 | (25%) 59.6K to 44.6K | |
| 14-Nov-24 4:35 PM View: | Chambers Rebecca Chief Financial Officer | Veracyte, Inc. (VCYT) | 12-Nov-24 | Private Sale (Planned) | 15,275 | $38.34 | $585,663.00 | (11%) 139.78K to 124.5K | |
| 14-Nov-24 4:35 PM View: | Epstein Robert S Director | Veracyte, Inc. (VCYT) | 12-Nov-24 | Option Exercise | 15,000 | $8.04 | $120,600.00 | 34% 44.6K to 59.6K | |
| 23-Sep-24 4:23 PM View: | Jones Evan/ Fa Director | Veracyte, Inc. (VCYT) | 19-Sep-24 | Market Sale (Planned) | 5,173 | $35.23 | $182,263.00 | (13%) 39.52K to 34.34K | 4% |
| 06-Sep-24 4:18 PM View: | Leite John Chief Commercial Officer-CLIA | Veracyte, Inc. (VCYT) | 04-Sep-24 | Market Sale (Planned) | 5,479 | $29.78 | $163,159.00 | (7%) 81.65K to 76.17K | (14%) |
| 04-Sep-24 4:19 PM View: | Miller Thomas F. Director | Veracyte, Inc. (VCYT) | 03-Sep-24 | Grant | 16,507 | -- | -- | 100% 0 to 16.51K | |
| 04-Sep-24 4:19 PM View: | Shafer David Brent Director | Veracyte, Inc. (VCYT) | 03-Sep-24 | Grant | 16,507 | -- | -- | 100% 0 to 16.51K | |
| 04-Sep-24 8:08 PM View: | McGuire Annie SVP, General Counsel | Veracyte, Inc. (VCYT) | 02-Sep-24 | Payment of Exercise | 1,920 | $31.55 | $60,576.00 | (2%) 95.41K to 93.49K | (8%) |
| 04-Sep-24 6:08 PM View: | Wygant Jonathan VP, Chief Accounting Officer | Veracyte, Inc. (VCYT) | 02-Sep-24 | Payment of Exercise | 1,087 | $31.55 | $34,294.80 | (2%) 48.43K to 47.34K | (8%) |
| 04-Sep-24 5:08 PM View: | Stapley Marc Chief Executive Officer Director | Veracyte, Inc. (VCYT) | 02-Sep-24 | Payment of Exercise | 5,748 | $31.55 | $181,349.00 | (2%) 324.43K to 318.68K | (8%) |
| 04-Sep-24 8:24 PM View: | Chambers Rebecca Chief Financial Officer | Veracyte, Inc. (VCYT) | 02-Sep-24 | Payment of Exercise | 3,464 | $31.55 | $109,289.00 | (2%) 143.24K to 139.78K | (8%) |
| 14-Aug-24 5:09 PM View: | Jones Evan/ Fa Director | Veracyte, Inc. (VCYT) | 13-Aug-24 | Planned Option Sale | 8,385 | $32.20 | $270,032.00 | (10%) 87.16K to 78.78K | |
| 14-Aug-24 5:09 PM View: | Jones Evan/ Fa Director | Veracyte, Inc. (VCYT) | 13-Aug-24 | Option Exercise | 8,486 | $10.41 | $88,339.30 | 11% 78.67K to 87.16K | |
| 14-Aug-24 5:09 PM View: | Jones Evan/ Fa Director | Veracyte, Inc. (VCYT) | 13-Aug-24 | Sale (Planned) | 12,072 | $32.20 | $388,769.00 | (15%) 78.78K to 66.7K | |
| 14-Aug-24 5:09 PM View: | Jones Evan/ Fa Director | Veracyte, Inc. (VCYT) | 13-Aug-24 | Sale (Planned) | 27,188 | $32.20 | $875,565.00 | (41%) 66.7K to 39.52K | |
| 14-Aug-24 5:09 PM View: | Jones Evan/ Fa Director | Veracyte, Inc. (VCYT) | 12-Aug-24 | Market Sale (Planned) | 99 | $30.01 | $2,970.50 | (< 1%) 78.88K to 78.78K | (13%) |
| 14-Aug-24 5:09 PM View: | Jones Evan/ Fa Director | Veracyte, Inc. (VCYT) | 12-Aug-24 | Market Option Sale (Planned) | 101 | $30.00 | $3,030.50 | (< 1%) 78.78K to 78.67K | (13%) |
| 13-Aug-24 4:38 PM View: | Jones Evan/ Fa Director | Veracyte, Inc. (VCYT) | 09-Aug-24 | Sale (Planned) | 746 | $30.03 | $22,401.60 | (< 1%) 79.62K to 78.88K | |
| 13-Aug-24 4:38 PM View: | Jones Evan/ Fa Director | Veracyte, Inc. (VCYT) | 09-Aug-24 | Planned Option Sale | 300 | $30.03 | $9,008.67 | (< 1%) 80.65K to 80.35K | |
| 13-Aug-24 4:38 PM View: | Jones Evan/ Fa Director | Veracyte, Inc. (VCYT) | 09-Aug-24 | Sale (Planned) | 732 | $30.03 | $21,981.20 | (< 1%) 80.35K to 79.62K | |
| 13-Aug-24 4:38 PM View: | Jones Evan/ Fa Director | Veracyte, Inc. (VCYT) | 09-Aug-24 | Option Exercise | 300 | $10.41 | $3,123.00 | < 1% 80.35K to 80.65K | |
| 09-Aug-24 4:47 PM View: | Jones Evan/ Fa Director | Veracyte, Inc. (VCYT) | 07-Aug-24 | Sale | 3,894 | $30.32 | $118,073.00 | (5%) 84.25K to 80.35K | |
| 09-Aug-24 4:47 PM View: | Holstein Jens Director | Veracyte, Inc. (VCYT) | 07-Aug-24 | Market Sale (Planned) | 5,000 | $29.00 | $145,000.00 | (15%) 32.88K to 27.88K | (17%) |
| 09-Aug-24 4:47 PM View: | Jones Evan/ Fa Director | Veracyte, Inc. (VCYT) | 07-Aug-24 | Option Exercise | 1,214 | $10.41 | $12,637.70 | 1% 84.25K to 85.46K | |
| 09-Aug-24 4:47 PM View: | Jones Evan/ Fa Director | Veracyte, Inc. (VCYT) | 07-Aug-24 | Option Sale | 1,214 | $30.32 | $36,810.50 | (1%) 85.46K to 84.25K | |
| 18-Jul-24 6:25 PM View: | Leite John Chief Commercial Officer-CLIA | Veracyte, Inc. (VCYT) | 16-Jul-24 | Sale (Planned) | 1,277 | $25.00 | $31,925.00 | (2%) 84.25K to 82.97K | |
| 18-Jul-24 6:25 PM View: | Eastham Karin Director | Veracyte, Inc. (VCYT) | 16-Jul-24 | Sale (Planned) | 7,500 | $25.00 | $187,500.00 | (18%) 40.73K to 33.23K | |
| 18-Jul-24 6:25 PM View: | Holstein Jens Director | Veracyte, Inc. (VCYT) | 16-Jul-24 | Sale (Planned) | 5,000 | $24.50 | $122,500.00 | (13%) 37.88K to 32.88K | |
| 17-Jun-24 4:48 PM View: | Bhanji Muna Director | Veracyte, Inc. (VCYT) | 13-Jun-24 | Grant | 11,473 | -- | -- | 50% 23.11K to 34.58K | |
| 17-Jun-24 4:49 PM View: | Jones Evan/ Fa Director | Veracyte, Inc. (VCYT) | 13-Jun-24 | Grant | 11,473 | -- | -- | 16% 72.77K to 84.25K | |
| 17-Jun-24 4:48 PM View: | Eastham Karin Director | Veracyte, Inc. (VCYT) | 13-Jun-24 | Grant | 11,473 | -- | -- | 39% 29.25K to 40.73K | |
| 17-Jun-24 4:48 PM View: | Holstein Jens Director | Veracyte, Inc. (VCYT) | 13-Jun-24 | Grant | 11,473 | -- | -- | 43% 26.41K to 37.88K | |
| 17-Jun-24 4:48 PM View: | Epstein Robert S Director | Veracyte, Inc. (VCYT) | 13-Jun-24 | Grant | 11,473 | -- | -- | 35% 33.13K to 44.6K | |
| 17-Jun-24 4:49 PM View: | Barr Eliav Director | Veracyte, Inc. (VCYT) | 13-Jun-24 | Grant | 11,473 | -- | -- | 38% 30.39K to 41.87K | |
| 13-Jun-24 4:24 PM View: | Eastham Karin Director | Veracyte, Inc. (VCYT) | 11-Jun-24 | Sale (Planned) | 3,870 | $20.59 | $79,683.30 | (12%) 33.13K to 29.25K | |
| 11-Jun-24 4:22 PM View: | Bhanji Muna Director | Veracyte, Inc. (VCYT) | 10-Jun-24 | Sale (Planned) | 3,870 | $20.32 | $78,633.80 | (14%) 26.98K to 23.11K | |
| 11-Jun-24 4:21 PM View: | Eastham Karin Director | Veracyte, Inc. (VCYT) | 07-Jun-24 | Option Exercise | 2,500 | $10.41 | $26,025.00 | 8% 33.13K to 35.63K | |
| 11-Jun-24 4:21 PM View: | Eastham Karin Director | Veracyte, Inc. (VCYT) | 07-Jun-24 | Planned Option Sale | 2,500 | $20.97 | $52,425.00 | (7%) 35.63K to 33.13K | |
| 04-Jun-24 4:42 PM View: | Wygant Jonathan VP, Chief Accounting Officer | Veracyte, Inc. (VCYT) | 02-Jun-24 | Payment of Exercise | 1,087 | $20.75 | $22,555.20 | (2%) 49.06K to 47.97K | |
| 04-Jun-24 4:42 PM View: | Stapley Marc Chief Executive Officer Director | Veracyte, Inc. (VCYT) | 02-Jun-24 | Payment of Exercise | 5,746 | $20.75 | $119,230.00 | (2%) 329.74K to 323.99K | |
| 04-Jun-24 4:43 PM View: | Chambers Rebecca Chief Financial Officer | Veracyte, Inc. (VCYT) | 02-Jun-24 | Payment of Exercise | 3,462 | $20.75 | $71,836.50 | (2%) 146.7K to 143.24K | |
| 04-Jun-24 4:43 PM View: | McGuire Annie SVP, General Counsel | Veracyte, Inc. (VCYT) | 02-Jun-24 | Payment of Exercise | 1,919 | $20.75 | $39,819.20 | (2%) 97.33K to 95.41K | |
| 04-Jun-24 4:42 PM View: | Leite John Chief Commercial Officer-CLIA | Veracyte, Inc. (VCYT) | 02-Jun-24 | Payment of Exercise | 1,314 | $20.75 | $27,265.50 | (2%) 85.56K to 84.25K | |
| 30-May-24 4:41 PM View: | Bhanji Muna Director | Veracyte, Inc. (VCYT) | 28-May-24 | Sale (Planned) | 1,539 | $21.00 | $32,319.00 | (5%) 28.51K to 26.98K | |
| 02-Apr-24 4:17 PM View: | Eastham Karin Director | Veracyte, Inc. (VCYT) | 01-Apr-24 | Option Exercise | 10,000 | $13.19 | $131,900.00 | 30% 33.13K to 43.13K | |
| 02-Apr-24 4:17 PM View: | Eastham Karin Director | Veracyte, Inc. (VCYT) | 01-Apr-24 | Planned Option Sale | 10,000 | $21.65 | $216,528.00 | (23%) 43.13K to 33.13K | |
| 19-Mar-24 4:49 PM View: | Stapley Marc Chief Executive Officer Director | Veracyte, Inc. (VCYT) | 15-Mar-24 | Payment of Exercise | 5,971 | $21.10 | $125,988.00 | (2%) 335.71K to 329.74K | |
| 19-Mar-24 4:50 PM View: | Chambers Rebecca Chief Financial Officer | Veracyte, Inc. (VCYT) | 15-Mar-24 | Grant | 4,318 | -- | -- | 3% 144.57K to 148.89K | |
| 19-Mar-24 4:50 PM View: | Chambers Rebecca Chief Financial Officer | Veracyte, Inc. (VCYT) | 15-Mar-24 | Payment of Exercise | 2,189 | $21.10 | $46,187.90 | (1%) 148.89K to 146.7K |
